YAP/TAZ cooperate with AP-1 to drive the mesenchymal cell state in neuroblastoma [RNAseq]
Single-cell RNA-seq · human · 36 samples
- What it is
- Single-cell RNA-seqGene activity measured in thousands of individual cells, so cell types can be told apart. Read from the summary: GEO's own type field only says 'expression profiling by sequencing', so confirm it in the paper.
- Organism
- Homo sapiens (human)
- Topic
- NeuroblastomaThis series is part of our curated briefing on it.
- Samples
- 36 samples: 6 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE275995_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Single-cell studies usually ship their counts as 10x files (matrix.mtx, barcodes.tsv, features.tsv), an .h5 file, or an .rds / .h5ad object that Seurat or Scanpy can open. Look for those among the supplementary files.
Also filed as BioProject PRJNA1154237 and SRA study SRP529437. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 18 samples.
How we read this: 6 replicated groups read from 36 sample titles; they account for 18 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8489166 STA-NB-8 Mesenchymal, rep1
- GSM8489167 SK-N-SH Mesenchymal, rep1
- GSM8489168 STA-NB-8 Adrenergic, rep1
- GSM8489169 CLB-Ma Mesenchymal, rep1
- GSM8489170 STA-NB-10 Mesenchymal, rep1
- GSM8489171 STA-NB-10 Adrenergic, rep1
- GSM8489172 CLB-Ma Adrenergic, rep1
- GSM8489173 SK-N-SH Adrenergic, rep1
- GSM8489174 CLB-Ma Over Expression Empty Vector, rep1
- GSM8489175 CLB-Ma Over Expression WWTR1, rep1
- GSM8489176 CLB-Ma Over Expression YAP1, rep1
- GSM8489177 SK-N-SH Over Expression Empty Vector, rep1
- GSM8489178 SK-N-SH Over Expression WWTR1, rep1
- GSM8489179 SK-N-SH Over Expression YAP1, rep1
- GSM9076872 CLB-Ma k-975 treatment 24h rep1 CLB-Ma k-975 treatment …
- GSM9076873 CLB-Ma k-975 treatment 24h rep2 CLB-Ma k-975 treatment …
- GSM9076874 CLB-Ma k-975 treatment 24h rep3 CLB-Ma k-975 treatment …
- GSM9076875 CLB-Ma k-975 treatment 48h rep1 CLB-Ma k-975 treatment …
- GSM9076876 CLB-Ma k-975 treatment 48h rep2 CLB-Ma k-975 treatment …
- GSM9076877 CLB-Ma k-975 treatment 48h rep3 CLB-Ma k-975 treatment …
- GSM9076878 CLB-Ma k-975 control treatment rep1 CLB-Ma k-975 control tr…
- GSM9076879 CLB-Ma k-975 control treatment rep2 CLB-Ma k-975 control tr…
- GSM9076880 CLB-Ma k-975 control treatment rep3 CLB-Ma k-975 control tr…
- GSM9076881 SK-N-SH k-975 treatment 24h rep1 SK-N-SH k-975 treatment…
- GSM9076882 SK-N-SH k-975 treatment 24h rep2 SK-N-SH k-975 treatment…
- GSM9076883 SK-N-SH k-975 treatment 24h rep3 SK-N-SH k-975 treatment…
- GSM9076884 SK-N-SH k-975 treatment 48h rep1 SK-N-SH k-975 treatment…
- GSM9076885 SK-N-SH k-975 treatment 48h rep2 SK-N-SH k-975 treatment…
- GSM9076886 SK-N-SH k-975 treatment 48h rep3 SK-N-SH k-975 treatment…
- GSM9076887 SK-N-SH k-975 control treatment rep1 SK-N-SH k-975 control t…
- GSM9076888 SK-N-SH k-975 control treatment rep2 SK-N-SH k-975 control t…
- GSM9076889 SK-N-SH k-975 control treatment rep3 SK-N-SH k-975 control t…
- GSM9076890 cell_line WWTR1 DMSO rep1
- GSM9076891 cell_line WWTR1 TDI rep1
- GSM9076892 cell_line WWTR1 DOX rep1
- GSM9076893 cell_line WWTR1 DOX + TDI rep1
- GSE164456 Histone lysine demethylase 4 family proteins maintain the transcriptional program and adrenergic cellular state of MYCN-amplified neuroblastoma 69 samples same disease briefing · shares neuroblastoma, state
- GSE183729 Single-cell MultiOmics and spatial transcriptomics demonstrate neuroblastoma developmental plasticity 18 samples same disease briefing · shares neuroblastoma
- GSE178937 RNA sequencing of neuroblastoma cells treated with selinexor or with XPO1 knockdown 12 samples same disease briefing · shares neuroblastoma
- GSE275538 Identification of EPLIN as a novel MYCN-independent target in neuroblastoma and medulloblastoma 1 samples same disease briefing · shares neuroblastoma
- GSE120572 A mechanistic classification of clinical phenotypes in neuroblastoma 394 samples same disease briefing · shares neuroblastoma
- GSE181582 IGF2BP1 induces neuroblastoma via a druggable feedforward loop with MYCN promoting 17q oncogene expression 264 samples same disease briefing · shares neuroblastoma
- GSE12494 SNP data from Neuroblastoma samples 262 samples same disease briefing · shares neuroblastoma
- GSE16476 Integrated bioinformatic and wet-lab approach to identify potential oncogenic networks in neuroblastoma 88 samples same disease briefing · shares neuroblastoma
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.